Bcl-2 and Bcl-X(L) antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents

Cancer Research

Volumn 57, Issue 1, 1997, Pages 62-67

  Decaudin, Didier ^a   Geley, Stephan ^b   Hirsch, Tamara ^a   Castedo, Maria ^a   Marchetti, Philippe ^a   Macho, Antonio ^a   Kofler, Reinhard ^b   Kroemer, Guido ^a  

^a CNRS   (France)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CERAMIDE; CYTARABINE; DNA FRAGMENT; DOXORUBICIN; ETOPOSIDE;

ADULT; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CROSS LINKING; CYTOFLUOROMETRY; DNA DETERMINATION; ENZYME INHIBITION; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA; LYMPHOMA; MALE; PRIORITY JOURNAL; PROTO ONCOGENE; TUMOR CELL CULTURE;

ADULT; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-X PROTEIN; COWPOX; CYTARABINE; DOXORUBICIN; ETOPOSIDE; HUMANS; MALE; MEMBRANE POTENTIALS; MIDDLE AGED; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; VIRAL PROTEINS;

EID: 0031032294     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Barr, P. J., and Tomei, L. D. Apoptosis and its role in human disease. Biotechnology, 12: 487-493, 1994.
2. Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science (Washington DC), 267: 1456-1462, 1995.
3. Vaux, D. L., Cory, S., and Adams, J. M. Bcl-2 promotes the survival of haemopoietic cells and cooperates with c-myc to immortalize pre-B cells. Nature (Lond.), 355: 440-442, 1988.
4. Hockenbery, D., Nuñez, G., Milliman, C., Schreiber, R. D., and Korsmeyer, S. J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (Lond.), 348: 334-338, 1990.
5. Reed, J. C. Bcl-2 and the regulation of programmed cell death. J. Cell Biol., 124: 1-6, 1995.
6. Cory, S. Regulation of lymphocyte survival by the Bcl-2 gene family. Annu. Rev. Immunol., 13: 513-543, 1995.
7. Hockenbery, D. M. Bcl-2 in cancer, development and apoptosis. J. Cell Sci., 18 (Suppl.): S51-S55, 1994.
8. Minn, A. J., Rdin, C. M., Boise, L. H., and Thompson, C. B. Expression of bcl-xL can confer a multidrug resistance phenotype. Blood, 86: 1903-1910, 1995.
9. Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., and Giaccia, A. J. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature (Lond.), 379: 88-91, 1996.
10. Jacobson, M. D., Burne, J. F., and Raff, M. C. Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J., 13: 1899-1910, 1994.
11. Schulze-Osthoff, K., Walczak, H., Dröge, W., and Krammer, P. H. Cell nucleus and DNA fragmentation are not required for apoptosis. J. Cell Biol., 127: 15-20, 1994.
12. Newmeyer, D. D., Farschon, D. M., and Reed, J. C. Cell-free apoptosis in Xenopus egg extracts: inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria. Cell, 79: 353-364, 1994.
13. Martin, S. J., Newmeyer, D. D., Mathisa, S., Farschon, D. M., Wang, H. G., Reed, J. C., Kolesnick, R. N., and Green, D. R. Cell-free reconstitution of Fas-, UV radiation-, and ceramide-induced apoptosis. EMBO J., 14: 5191-5200, 1995.
14. Enari, M., Hase, A., and Nagata, S. Apoptosis by a cytosolic extract from Fas-activated cells. EMBO J., 14: 5201-5208, 1995.
15. Kroemer, G., Petit, P. X., Zamzami, N., Vayssière, J.-L., and Mignotte, B. The biochemistry of apoptosis. FASEB J., 9: 1277-1287, 1995.
16. Zamzami, N., Marchetti, P., Castedo, M., Zanin, C., Vayssière, J.-L., Petit, P. X., and Kroemer, G. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med., 181: 1661-1672, 1995.
17. Petit, P. X., LeCoeur, H., Zorn, E., Dauguet, C., Mignotte, B., and Gougeon, M. L. Alterations of mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J. Cell Biol., 130: 157-167, 1995.
18. Zamzami, N., Marchetti, P., Castedo, M., Decaudin, D., Macho, A., Hirsch, T., Susin, S. A., Petit, P. X., Mignotte, B., and Kroemer, G. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med., 182: 367-377, 1995.
19. Zamzami, N., Susin, S. A., Marchetti, P., Hirsch, T., Gómez-Monterrey, I., Castedo, M., and Kroemer, G. Mitochondrial control of nuclear apoptosis. J. Exp, Med., 183: 1533-1544, 1996.
20. Marchetti, P., Susin, S. A., Decaudin, D., Garnen, S., Castedo, M., Hirsch, T., Zamzami, N., Naval, J., Senik, A., and Kroemer, G. Apoptosis-associated derangement of mitochondrial function in cells lacking mitochondria! DNA. Cancer Res., 56: 2033-2038, 1996.
21. Deckwerth, T. L., and Johnson, E. M. Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J. Cell Biol., 123: 1207-1222, 1993.
22. Vayssière, J.-L., Petit, P. X., Risler, Y., and Mignotte, B. Commitment to apoptosis is associated with changes in mitochondrial biogenesis and activity in cell lines conditionally immortalized with simian virus 40. Proc. Natl. Acad. Sci. USA, 91: 11752-11756, 1994.
23. Green, D. R., Mahboubi, A., Nishioka, W., Oja, S., Echeverri, F., Shi, Y., Glynn, J., Yang, Y., Ashwell, J., and Bissonnette, R. Promotion and inhibition of activation-induced apoptosis in T-cell hybridomas by oncogens and related signals. Immunol. Rev., 142: 321-342, 1994.
24. Cuende, E., Alés-Martínez, J. E., Ding, L., Gonzalez-Garcia, M., Martínez-A., C., and Nuñez, G. Programmed cell death by Bcl-2-dependent and -independent mechanisms in B-cell lymphoma cells. EMBO J., 12: 1555-1560, 1993.
25. Choi, M. S. K., Boise, L. H., Gottschalk, A. R., Quintans, J., Thompson, C. B., and Klaus, G. G. B. The role of bcl-x(L) in CD40-mediated rescue from anti-mu-induced apoptosis in WEHI-231 B lymphoma cells. Eur. J. Immunol., 25: 1352-1357, 1995.
26. Strasser-Wozak, E., Hattmannstorfer, R., Hala, M., Hartmann, B. L., Fiegl, M., Geley, S., and Kofler, R. Splice site mutation in the glucocorticoid receptor gene causes resistance to glucocorticoid-induced apoptosis in a human acute leukemic cell line. Cancer Res., 55: 348-353, 1995.
27. Gagliardini, V., Fernandez, P. A., Lee, R. K., Drexler, H. C., Rotello, R. J., Fishman, M. C., and Yuan, J. Prevention of vertebrate neuronal death by the crmA gene. Science (Washington DC), 263: 826-828, 1994.
28. Pittaluga, S., Bijnens, L., Teodorovic, I., Hagenbeek, A., Meerwaldt, J. H., Somers, R., Thomas, J., Noordijk, E. M., and De-Wolf-Peeters, C. Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative group subtyped according to the Revised European American Classification of Lymphoid Neoplasms: a comparison with the Working Formulation. Blood, 87: 4358-4367, 1996.
29. Vadlamudi, G., Lionetti, K. A., Greenberg, S., and Mehta, K. Leukemic phase of mantle cell lymphoma: two case reports and review of the literature. Arch. Pathol. Lab. Med., 120: 35-40, 1996.
30. Rothe, G., and Valet, G. Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2′,7′-dichlorofluorescein. J. Leukocyte Biol., 47: 440-448, 1990.
31. Nicoletti, I., Migliorati, G., Pagliacci, M. C., and Riccardi, C. A rapid simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods, 139: 271-280, 1991.
32. Gottschalk, A. R., Boise, L. H., Thompson, C. B., and Quintans, J. Identification of immunosuppressant-induced apoptosis in a murine B cell line and its prevention by bcl-x but not bcl-2. Proc. Natl. Acad. Sci. USA, 91: 7350-7354, 1994.
33. Nicolli, A., Basso, E., Petronilii, V., Wenger, R. M., and Bernardi, P. Interactions of cyclophilin with mitochondrial inner membrane and regulation of the permeability transition pore, a cyclosporin A-sensitive channel. J. Biol. Chem., 271: 2185-2192, 1996.
34. Zamzami, N., Marchetti, P., Castedo, M., Hirsch, T., Susin, S. A., Masse, B., and Kroemer, G. Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett., 384: 53-57, 1996.
35. Boise, L. H., González-García, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nuñez, G., and Thompson, C. B. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic death. Cell, 74: 597-608, 1993.
36. González-García, M., Perez-Ballestero, R., Ding, L. Y., Duan, L., Boise, L. H., Thompson, C. B., and Nuñez, G. Bcl-xL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. Development (Camb.), 120: 3033-3042, 1994.
37. Shimizu, S., Eguchi, Y., Kosaka, H., Kamlike, W., Matsuda, H., and Tsujimoto, Y. Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature (Lond.), 374: 811-813, 1995.
38. Ray, C. A., Black, R. A., Kronheim, S. R., Greenstreet, T. A., Sleath, P. R., Salvesen, G. S., and Pickup, D. J. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme. Cell, 69: 587-609, 1992.
39. Tewari, M., Quan, L. T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D. R., Poirier, G. G., Salvesen, G. S., and Dixit, V. M. Yama/CPP32 β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell, 81: 801-809, 1995.
40. Los, M., Van de Craen, M., Penning, L. C., Schenk, H., Westendorp, M., Bauerle, P. A., Droge, W., Krammer, P. H., Fiers, W., and Schulze-Osthoff, K. Requirement of an ICE/CED-3 protease for Fas/Apo-1-mediated apoptosis. Nature (Lond.), 375: 81-83, 1995.
41. Enari, M., Hug, H., and Nagata, S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature (Lond.), 375: 78-81, 1995.
42. Tewari, M., and Dixit, V. M. Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem., 270: 3255-3260, 1995.
43. Memon, S. A., Moreno, M. B., Petrak, D., and Zacharchuk, C. M. Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T-cell hybridoma. J. Immunol., 155: 4644-4652, 1995.
44. Strasser, A., Harris, A. W., Huang, D. C. S., Krammer, P. H., and Cory, S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J., 14: 6136-6147, 1995.
45. Friesen, C., Herr, I., Krammer, P. H., and Debatin, K.-M. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat. Med., 2: 574-577, 1996.
46. Alnemri, E. S., Robertson, N. M., Fernandes, T. F., Croce, C. M., and Litwack, G. Overexpressed full-length human BCL2 extends the survival of baculovirus-infected Sf9 insect cells. Proc. Natl. Acad. Sci. USA, 89: 7295-7299, 1992.
47. Hockenbery, D. M., Oltvai, Z. N., Yin, X.-M., Milliman, C. L., and Korsmeyer, S. J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell, 75: 241-251, 1993.
48. Tanaka, S., Saito, K., and Reed, J. C. Structure-function analysis of the Bcl-2 oncoprotein. Addition of a heterologous transmembrane domain to portions of the Bcl-2§ protein restores function as a regulator of cell survival. J. Biol. Chem., 268: 10920-10926, 1993.
49. Nguyen, M., Branton, P. E., Walton, P. A., Oltvai, Z. N., Korsmeyer, S. J., and Shore, G. C. Role of membrane anchor domain of Bcl-2 in suppression of apoptosis caused by E1B-defective adenovirus. J. Biol. Chem., 269: 16521-16524, 1994.
50. Borner, C., Martinou, I., Mattmann, C., Irmler, M., Schaerer, E., Martinou, J. C., and Tschopp, J. The protein bcl-2α does not require membrane attachment, but two conserved domains to suppress apoptosis. J. Cell Biol., 126: 1059-1068, 1994.
51. Hanada, M., Aimesempe, C., Sato, T., and Reed, J. C. Structure-function analysis of Bcl-2 protein identification of conserved domains important for homodimerization with Bcl-2 and heterodimerization with Bax. J. Biol. Chem., 270: 11962-11969, 1995.
52. Greenhalf, W., Stephan, C., and Chaudhuri, B. Role of mitochondria and C-terminal membrane anchor of Bcl-2 in Bax-induced growth arrest and mortality in Saccharomyces cerevisiae, FEBS Lett., 380: 169-175, 1996.
53. Hunter, J. J., Bond, B. L., and Parslow, T. G. Functional dissection of the human Bc12 protein: sequence requirements for inhibition of apoptosis. Mol. Cell. Biol., 16: 877-883, 1996.
54. Muchmore, S. W., Sattler, M., Liang, H., Meadows, R. P., Harlan, J. E., Yoon, H. S., Nettesheim, D., Chang, B. S., Thompson, C. B., Wong, S.-L., Ng, S.-H., and Fesik, S. W. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature (Lond.), 387: 335-341, 1996.
55. Susin, S. A., Zamzami, N., Castedo, M., Hirsch, T., Marchetti, P., Macho, A., Daugas, E., Geuskens, M., and Kroemer, G. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med., 184: 1331-1342, 1996.
56. Liu, X., Kim, C. N., Yang, J., Jemmerson, R., and Wang, X. Induction of apoptic program in cell-free extracts: requirement for dATP and cytochrome C. Cell, 86: 147-157, 1996.
57. Chen, L. B. Mitochondrial membrane potential in living cells. Annu. Rev. Cell Biol., 4: 155-181, 1988.